| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5898939 | Diabetes Research and Clinical Practice | 2016 | 14 Pages |
Abstract
The information gained from PROs in clinical trial research is important in defining treatment benefit within the context of the trial, and the potential benefit (i.e. better adherence) in clinical practice. However, variable results have been observed in recent trials and careful and systematic consideration should be given to PRO selection for future studies of T2D.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Matthew Reaney, Celeste A. Elash, Leighann Litcher-Kelly,